The effect of carnitine supplementation for the liver cirrhosis patients with hyperammonemia -a preliminary randomized controlled study
Not Applicable
Recruiting
- Conditions
- Cirrhosis
- Registration Number
- JPRN-UMIN000008723
- Lead Sponsor
- Tokai University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who are difficult to continue this study for treatment of hepatocarcinoma. 2.Patients complicated uncontrolled diabets. 3.Patients who diagnosed unfitness to attend the study by a physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is to evaluate the change of blood ammonia level.
- Secondary Outcome Measures
Name Time Method